Olagunju Peter

Track

Insider profile

Olagunju Peter's trades of TCR2 Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
202.84
Quantity 69,533 +46.5%
Value US$2,760,988
Transaction date
Planned sale
Price
393.33
Quantity 73,177 -44.8%
Value US$1,473,490
Transaction date
Planned sale
Price
344.54
Quantity 97,751 +40.9%
Value US$1,051,199
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-12-13 2022-12-13
PlS Planned sale
69,533 +46.5%
202.84
US$2,760,988 		69,533 +46.5% 202.84 US$2,760,988
2022-12-13 2022-12-12
PlS Planned sale
73,177 -44.8%
393.33
US$1,473,490 		73,177 -44.8% 393.33 US$1,473,490
2022-12-13 2022-12-09
PlS Planned sale
97,751 +40.9%
344.54
US$1,051,199 		97,751 +40.9% 344.54 US$1,051,199
2022-12-09 2022-12-08
PlS Planned sale
1,410 -4.6%
1.25
US$1,767 		1,410 -4.6% 1.25 US$1,767
2022-12-09 2022-12-07
PlS Planned sale
1,378 -4.3%
1.28
US$1,767 		1,378 -4.3% 1.28 US$1,767
2022-12-07 2022-12-06
PlS Planned sale
1,327 -4.0%
1.33
US$1,765 		1,327 -4.0% 1.33 US$1,765
2022-12-07 2022-12-05
PlS Planned sale
1,291 -3.8%
1.37
US$1,766 		1,291 -3.8% 1.37 US$1,766
2022-12-05 2022-12-02
PlS Planned sale
1,273 -3.6%
1.39
US$1,766 		1,273 -3.6% 1.39 US$1,766